Related Experiment Videos
Electroencephalogram alterations during treatment with olanzapine
F Pillmann1, K Schlote, K Broich
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Martin-Luther-Universität Halle-Wittenberg, Halle, Germany.
Psychopharmacology
|July 25, 2000
Summary
Olanzapine, an antipsychotic, did not increase seizure-related EEG abnormalities. However, it was linked to more non-specific EEG slowing, suggesting careful monitoring for patients with seizure risk factors is needed.
Area of Science:
- Neuroscience
- Pharmacology
- Clinical Psychiatry
Background:
- Olanzapine shares structural and pharmacological similarities with clozapine.
- Clozapine is associated with increased EEG abnormalities and seizures, unlike olanzapine, though rare seizure cases exist.
Purpose of the Study:
- To determine the incidence of epileptic and non-epileptiform electroencephalogram (EEG) abnormalities during olanzapine treatment.
- Investigate potential EEG changes associated with olanzapine therapy.
Main Methods:
- Blind rating of 43 patient EEGs using a reliable scale.
- Comparison of EEGs from patients on olanzapine (10-25 mg/day) with their own EEGs on other medications.
- Controlled assessment of EEG activity in routine olanzapine users.
Main Results:
- No significant difference in epileptiform activity was observed between olanzapine and other medications.
- EEG slowing was significantly more frequent when patients were treated with olanzapine.
- Concomitant medications did not account for the observed EEG slowing.
Conclusions:
- Olanzapine does not appear to increase epileptiform EEG activity.
- Unspecific EEG abnormalities, such as slowing, may be more common with olanzapine compared to other neuroleptics.
- Close monitoring of patients with seizure risk factors is recommended; further research on EEG changes is warranted.